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A TGF-b1-Dependent Autocrine Loop Regulates
the Structure of Focal Adhesions in Hypertrophic
Scar Fibroblasts
Ganary Dabiri1, Anelisa Campaner2, Jeffrey R. Morgan2 and Livingston Van De Water1
Following injury, fibroblasts migrate into wounds and differentiate into a smooth muscle cell actin (SMCA)-
positive cells, termed myofibroblasts, that assemble and remodel the scar. Cultured myofibroblasts assemble
larger focal adhesions than do normal dermal fibroblasts and these focal adhesions attach to a SMCA-rich
stress fibers. Following severe traumatic or thermal injury to the dermis, hypertrophic scars (HTSs) often
develop and these scar fibroblasts (HTSFs) express a SMCA persistently. We now report that HTSFs stably
display large focal adhesions as a consequence of both the autocrine production and activation of transforming
growth factor b1 (TGF-b1). We also observe that myofibroblasts elaborating larger focal adhesions adhere more
tightly to fibronectin. Conditioned medium from HTSFs induces focal adhesion growth in normal fibroblasts
and this is blocked by pre-incubation with a soluble TGF-b1 receptor mimetic. Human foreskin fibroblasts
transduced with a retrovirus encoding active TGF-b1 elaborate large focal adhesions, whereas fibroblasts
overexpressing normal, latent TGF-b1 do not. We conclude that the large focal adhesions found in pathogenic
myofibroblasts arise through an autocrine loop involving the production and activation of TGF-b1; these
adhesions likely mediate both tighter adhesion to wound matrix and the exuberant wound contraction
observed in pathogenic scars.
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INTRODUCTION
Pathogenic scarring and organ fibrosis result from the
persistent activity of myofibroblasts that deposit excessive
scar proteins and actively contract wounds. These processes
often lead to disfiguring scars, impaired joint mobility, and
reduced organ function. Despite the central importance of
the myofibroblasts in these disease processes, the mechan-
isms controlling fibroblast differentiation into myofibroblasts
are still largely unknown (Tomasek et al., 2002). The current
model holds that fibroblasts migrate into the wound bed in
response to growth factors, such as transforming growth
factor beta (TGF-b) and platelet-derived growth factor, where
they proliferate, differentiate, and deposit an abundant
extracellular matrix rich in collagen and fibronectin (Hynes,
1990; Clark, 1996; Martin, 1997). Wound myofibroblasts
elaborate focal adhesions that link the extracellular matrix to
the actin-containing cytoskeleton via integrins and accessory
proteins such as vinculin, talin, and a-actinin. Importantly,
focal adhesions also serve as signaling centers integrating
mechanical and growth factor signals with those from the
extracellular matrix (Burridge and Chrzanowska-Wodnicka,
1996; Geiger et al., 2001; Chen et al., 2004).
The transition from fibroblast to myofibroblast – with
concomitant induction of the marker a smooth muscle cell
actin (SMCA) – is thought to be regulated by the combined
action of three different agents: mechanical tension, active
TGF-b1, and an alternatively spliced variant of cellular
fibronectin (Serini et al., 1998; Tomasek et al., 2002).
Blocking the EIIIA domain of cellular fibronectin has been
reported to inhibit SMCA and collagen type I mRNA
induction by TGF-b1 in myofibroblasts (Serini et al., 1998).
TGF-b is a critical regulator of the myofibroblast phenotype
and has been reported to promote the growth of focal
adhesions into larger adhesions, termed ‘‘supermature’’ focal
adhesions (X6 mm2) (Dugina et al., 2001).
Hypertrophic scars (HTSs), a pathogenic form of scarring
in the skin, develop after thermal injury or surgery to the deep
dermis. HTSs tend to be erythematous, pruritic, thick, and
raised and, unlike keloids, remain within the boundary of the
original trauma site (Tuan and Nichter, 1998). Histological
examination of HTS reveals distinct nodules that contain an
excessive number of fibroblasts along with myofibroblasts,
small vessels, and fine collagen fibers that are arranged
& 2006 The Society for Investigative Dermatology www.jidonline.org 963
ORIGINAL ARTICLE
Received 8 July 2005; revised 11 November 2005; accepted 5 December
2005; published online 23 February 2006
1Center for Cell Biology and Cancer Research, Albany Medical College,
Albany, New York, USA and 2Department of Molecular Pharmacology,
Physiology, and Biotechnology, Brown University, Providence,
Rhode Island, USA
Correspondence: Dr Livingston Van De Water, Center for Cell Biology and
Cancer Research, MC-165, Albany Medical College, 47 New Scotland
Avenue, Albany, New York 12208, USA. E-mail: vandewl@mail.amc.edu
Abbreviations: ECM, extracellular matrix; HFF, human foreskin fibroblast;
HTS, hypertrophic scar; HTSF, fibroblast from hypertrophic scar; NADF,
normal adult human dermal fibroblast; pFN, plasma fibronectin; SMCA, a
smooth muscle cell actin; TGF-b1, transforming growth factor beta 1
parallel to the surface of the skin (Ehrlich et al., 1994).
Myofibroblasts, highly contractile cells, are thought
to be central to the excessive contraction observed in
HTS (Nedelec et al., 2000; Hinz et al., 2001; Hinz and
Gabbiani, 2003; Shin and Minn, 2004). Unfortunately,
the mechanisms underlying the development of HTSs are
not understood and there are presently no animal models
for this disease. Because fibroblasts within HTSs hyper-
contract the healing wound and focal adhesions link the cell
to the extracellular matrix (ECM), we postulated that
determining the size of these adhesions, how they grow,
and the function of these larger adhesions would further our
understanding the mechanisms that result in the pathogenesis
of this disorder.
We report here that cultured fibroblasts derived from
hypertrophic scars (HTSFs) stably exhibit an autocrine
induction of TGF-b1 that promotes the assembly and
maintenance of large focal adhesions. Addition of active
TGF-b1 to human foreskin fibroblasts (HFFs) and normal
human dermal fibroblasts (NADFs) drives increases in focal
adhesion areas and in cell adhesion to the extent observed
with HTSFs. Inhibition by a soluble TGF-b receptor mimetic
of active TGF-b1 in conditioned medium from HTSFs
reverses focal adhesion growth, confirming that autocrine
stimulation occurs leading to focal adhesion maturation.
Retroviral transduction of a constitutively active TGF-b1 is
sufficient to generate supermature focal adhesions. We
conclude that the induction of large focal adhesions aid in
myofibroblasts binding to ECM and that these processes are
mediated by the autocrine induction of TGF-b1.
RESULTS
TGF-b1 promotes maturation of focal adhesions
Immunofluorescence microscopy was used to analyze the
association of vinculin with phalloidin-stained stress fibers in
HFFs, NADFs, and HTSFs; we defined ‘‘focal adhesions’’ as
vinculin-positive adhesive structures in contact with stress
fibers. Focal adhesions, also termed ‘‘focal contacts’’ in the
literature, are to be distinguished from focal complexes that
are assembled at the cell periphery and are not in contact
with stress fibers. We sought to determine the role of TGF-b1
in regulating the areas of focal adhesions in normal dermal
fibroblasts and in HTSFs. Experiments were conducted by
culturing cells, with or without TGF-b1 (10 ng/ml) treatment,
for either 3, 4, or 5 days in serum-free medium. Focal
adhesion areas were measured (approximately 2,000 per
experimental condition) and presented graphically as the
proportion of the total number of focal adhesions falling
within a specific size group. Importantly, we did not observe
an appreciable difference in the number of focal adhesions
per cell (B100 adhesions/cell) for any of the cells we
examined. However, we did notice that the total number of
focal complexes decreased as the focal adhesions increased
in size in the cells treated with TGF-b1. This observation is
consistent with a model in which focal complexes are the
precursors of focal adhesions (Zaidel-Bar et al., 2004). In
addition, the area of the cells did not change in size when
treated with TGF-b1.
Immunoblots for the soluble and insoluble fraction of cells
using vinculin antibody showed no change in the total pool
of vinculin; however, there was an observable difference in
the amount of vinculin in the insoluble fraction: HTSFs
expressed higher levels of vinculin compared to HFFs (data
not shown). When exogenous TGF-b1 was added to HFFs
(Figure 1b) and NADFs (Figure 1d) for 5 days, the focal
adhesions noticeably increased in area. Focal adhesions in
HTSFs without exogenous TGF-b1 were much larger (7
1.5%) than those in untreated HFFs and NADFs (7 3.5%
Figure 1e compared to Figure 1a and c). Addition of TGF-b1
to HTSFs did not result in any noticeable changes in focal
adhesion size (Figure 1f). Mouse IgG was used a negative
control, to ensure that staining was specific.
We quantitated the area of the focal adhesions in each cell
and treatment group (Figure 2) and observed that the focal
adhesions in HFFs and NADFs treated with TGF-b1 for 5 days
were comparable to those in untreated HTSFs (Figure 2e
compared to Figure 2b and d) at the same time points,
suggesting that autocrine production and activation of TGF-
b1 occurred in HTSFs. There was an 8- and a 5.7-fold
induction in the proportion of focal adhesions that were
X6 mm2 in HFFs and NADFs, respectively, when treated with
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Figure 1. Focal adhesion staining at 5 days incubation. HFFs, NADFs, and
HTSFs were incubated in serum-free media either with or without TGF-b1
(10 ng/ml), fixed, and stained for vinculin (green), stress fibers (red), and DNA
(blue). By the fifth day of incubation, HFFs and NADFs with TGF-b1 (b, d) and
HTSFs (f) with or (e) without TGF-b1 expressed large focal adhesions (vinculin
in contact with stress fiber) compared to HFFs and NADFs without TGF-b1
(a, c). Bar¼20 mm.
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TGF-b1 compared to HFFs and NADFs without TGF-b1
(compare Figure 2b and d with a and c). Of note, the addition
of exogenous TGF-b1 to HTSFs did not elaborate larger
adhesions compared to no treatment, suggesting that the
mechanisms supporting focal adhesion growth were satu-
rated. Experiments were conducted to examine the area of
focal adhesions when cells were treated with TGF-b1 for 3
and 4 days, and there was no appreciable difference in
maturation of focal adhesions in HFFs and NADFs compared
to control (data not shown). Because the areas of focal
adhesions in HFFs and NADFs (treated 5 days with TGF-b1)
were similar to areas in HTSFs without TGF-b1, we incubated
all subsequent experiments for 5 days. Analysis of SMCA
expression demonstrated that HFFs and NADFs without TGF-
b1 contained a negligible amount of SMCA when analyzed
by immunoblotting at days 3 and 5. However, HFFs and
NADFs treated with exogenous TGF-b1 expressed an
abundant amount of SMCA (day 5), and these levels were
comparable to those observed with HTSFs with or without
TGF-b1 (data not shown). These results demonstrated that in
the presence of exogenous TGF-b1, both HFFs and NADFs
differentiated into myofibroblasts that elaborated large focal
adhesions. These data also suggest that HTSFs elaborate an
autocrine loop that generates active TGF-b1, which may be
responsible for the maturation of focal adhesions.
Transfer of HTSFs conditioned medium to HFF promotes focal
adhesion maturation
To determine whether or not TGF-b1 was present in
conditioned media, supporting a postulated role for autocrine
induction of TGF-b1 in HTSFs, we obtained supernatants
from HTSF, NADF, or HFF cultures and assayed them for
levels of either total or active TGF-b1 using a commercial
sandwich ELISA (R&D Systems, Inc., Minneapolis, MN).
Culture supernatants were prepared from cells grown in
serum-free medium for 5 days at 30% confluency. The
levels of total TGF-b1 (latent plus active) in conditioned
media were 6.75 ng/106 cells for three independent, primary
cultures of HTSFs, whereas for both types of normal
fibroblasts (HFFs and NADFs) the levels were 1.3 ng/106cells.
When the conditioned media from the above cells were
assayed only for the active form of TGF-b1, a marked
difference was observed: HTSFs secreted 3.0 ng/106cells,
whereas NADFs and HFFs produced 0.15 ng/106cells (data
not shown).
We then reasoned that conditioned medium from HTSFs
should promote focal adhesion maturation in HFFs. To test
this, we incubated otherwise untreated ‘‘indicator’’ HFF cells
for 5 days with medium conditioned for 5 days from either
HFFs (Figure 3a) or HTSFs (Figure 3b) and measured the focal
adhesions in the indicator HFFs. Conditioned medium of
HFFs added to ‘‘indicator’’ HFFs did not cause focal
adhesions to mature; 3% of focal adhesions were X6 mm2
but o10 mm2 (Figure 3a). However, focal adhesions in
indicator HFFs cultivated in conditioned medium derived
from HTSFs contained 2-fold more adhesions that were
X6 mm2 (Figure 3b).
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Figure 2. Focal adhesions in HTSFs mature independently of exogenous
active TGF-b1. Focal adhesions immunostained as in Figure 1 were
measured using Image Pro-Plus (0.1 mm2–50mm2). By the fifth day, HFFs and
NADFs with TGF-b1 (b, d) and HTSFs without TGF-b1 (e) contained a large
number of supermature focal adhesions (X6 mm2). However without addition
of TGF-b1, focal adhesions in HFFs (a) and NADFs (c) failed to mature.
*Po0.05 compared to 5 days HFFs and NADFs without TGF-b. **Po0.05
compared to HFFs and NADFs without TGF-b1. ( X0.1 mm2, o6 mm2),
( X6 mm2, o10 mm2), ( X10 mm2, o15 mm2), ( X15 mm2, o20 mm2),
( X20mm2, o25mm2), ( X25mm2, o30mm2), ( X30mm2, o50mm2).
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Figure 3. Media conditioned (CM) from HTSFs then transferred to HFFs
caused focal adhesions to mature. Conditioned media were prepared from
HTSFs or HFFs (control) in serum-free medium incubated for 5 days and
transferred to ‘‘indicator’’ HFFs for 5 days. Indicator HFFs were stained and
focal adhesions were measured as previously described. Note, (b) media from
HTSFs caused adhesions to mature in HFF cells. (a) Focal adhesions from
HFFs test media to indicator HFFs did not cause focal adhesions to mature.
Vinculin (green), stress fibers (red), and DNA (blue). *Po0.05. ( X0.1mm2,
o6 mm2), ( X6 mm2, o10 mm2), ( X10 mm2, o15 mm2), ( X15 mm2,
o20mm2), ( X20 mm2, o25 mm2), ( X25 mm2, o30 mm2), ( X30 mm2,
o50mm2). Bar¼20 mm.
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Addition of a TGF-b1 receptor antagonist to HTSFs inhibited the
maturation of focal adhesions
To determine the extent to which TGF-b1 was necessary for
focal adhesion maturation in HTSFs, we added a TGF-b1
receptor antagonist (Tb1RA) to serum-free medium on day
zero and allowed HTSFs to incubate for 5 days (Figure 4).
Earlier work demonstrated that this chimera, bearing the Fc
portion of IgG, has a half-life of B5 days in blood plasma
(Smith et al., 1999). The focal adhesion areas were then
measured and we observed a statistically significant decrease
in the proportion of large (X6mm2) focal adhesions when the
Tb1RA was added to HTSFs (Figure 4a compared to Figure 4b).
These results supported our hypothesis that HTSFs produced
active TGF-b1 and, as a consequence, induced focal adhesion
maturation. To prove that conditioned medium from HTSFs
contained TGF-b1 that was responsible for the observed focal
adhesion maturation, we incubated indicator HFFs with
conditioned medium from HTSFs to which the Tb1RA had
been added (Figure 4d). As a control, we first established that
the addition of the Tb1RA itself did not change the area of
focal adhesions in indicator HFFs (Figure 4c). When the
Tb1RA was added to the conditioned medium of HTSFs and
immediately transferred to indicator HFFs, focal adhesions did
not mature (Figure 4d) as they did in the absence of Tb1RA
(3.7-fold reduction compared to Figure 3b).
Retrovirally transduced fibroblasts over-expressing active
TGF-b1 generate supermature (X6 lm2) focal adhesions
The experiments described above tested the necessity of TGF-
b for HTSFs focal adhesion maturation. To determine whether
or not TGF-b1 was sufficient, we engineered HFF cells with a
retrovirus encoding either active (Figure 5b) or latent TGF-b1
(Figure 5a) to mimic autocrine induction found in HSTF. The
construct encoding latent TGF-b1 directed the synthesis of a
protein fully capable of conversion by acid treatment to an
active form. Total TGF-b1 secretion (latent plus active) was
measured by ELISA (R&D Systems, Inc., Minneapolis, MN)
using a modified protocol in which, these cells were plated in
serum-free media for 5 days at 30% confluency. HFFs
modified with the virus encoding the wild-type latent gene
produced 3.26 ng/106cells of total TGF-b1. HFFs modified
with the virus encoding the mutant active gene produced
7.75 ng/106cells of total TGF-b1. Importantly, the assay for
total TGF-b1 is performed by acid-treatment demonstrating
that the latent gene product is competent to be activated.
When the conditioned media from the above cells were
assayed only for the active form of TGF-b1, cells expressing
latent TGF-b1 secreted 0.70 ng/106 cells of active TGF-b1,
whereas cells expressing the active mutant TGF-b1 produced
4.01 ng/106cells of active TGF-b1. Cells of either genotype
were cultivated in serum-free medium for 5 days and the focal
adhesion areas were measured. Focal adhesions in cells
treated with active TGF-b1 contained 12 times more super-
mature focal adhesions (X6mm2) compared to cells with the
latent TGF-b1. This confirmed TGF-b1’s role as a major
cytokine involved in the maturation of focal adhesions and,
importantly, that HTSFs propagate an autocrine loop that
generates active TGF-b1 promoting focal adhesion maturation.
Supermature focal adhesions cause cells to bind tighter to
plasma fibronectin
To determine a possible functional correlate for the above
findings, we tested whether and to what extent the presence
81.78%
11.48%
4.16%
1.58%
0.72%
0.14%
0.14%
92.26%
∗
0.74%6.27%
HTSF in SF +T1RA HTSF in SF –T1RA
HTSF CM +T1RA to HFF HTSF CM +T1RA to HFF
1.04%
98.96% 98.30%
1.32% 0.44%
c d
a b
Figure 4. Addition of a TGF-Tb1RA inhibited focal adhesion maturation in
HTSFs. HTSFs were placed in serum-free media (SF) with (left) or without
(right) the addition of a Tb1RA (150–200 mg/ml) at day 0. After 5 days, HTSFs
were fixed, stained and focal adhesions were measured as previously
described. (a, b) The addition of the Tb1RA caused a seven-fold decrease in
the amount focal adhesions that wereX10mm2. (c, d) HTSF and HFF CM was
transferred to ‘‘indicator’’ HFFs in the presence of a Tb1RA (150–200 mg/ml).
After 5 days of incubation, cells were fixed, stained, and focal adhesions
measured as previously described. (d) The presence of the Tb1RA inhibited
indictor HFFs from maturing in conditioned media from HTSFs. *Po0.05
compared to HTSFs in SF-Tb1RA. ( X0.1 mm2, o6 mm2), ( X6 mm2,
o10mm2), ( X10 mm2, o15 mm2), ( X15 mm2, o20 mm2), ( X20 mm2,
o25mm2), ( X25 mm2, o30 mm2), ( X30 mm2, o50 mm2).
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Figure 5. HFFs transduced with a retrovirus encoding active TGF-b1
expressed super-mature focal adhesions. HFFs transduced with either latent
(left) or active (right) TGF-b1. Experimental design was described in Figures 1
and 2. Cells that contained active TGF-b1 (b) had 12 times more supermature
focal adhesions (X6 mm2) compared to cells that contained latent TGF-b1 (a).
vinculin (green), stress fiber (red), and DNA (blue). *Po0.05. ( X0.1 mm2,
o6 mm2), ( X6 mm2, o10 mm2), ( X10 mm2, o15 mm2), ( X15 mm2,
o20mm2), ( X20 mm2, o25 mm2), ( X25 mm2, o30 mm2), ( X30 mm2,
o50mm2). Bar¼20 mm.
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of larger adhesions in cells correlated with tighter adhesion to
matrix protein. In this experimental plan, we tested specifi-
cally the impact of intracellular processes (eg focal adhe-
sions) rather than the combined effects of these with
extracellular matrix synthesis and assembly. To do so, we
performed an adhesion assay using either HFFs or HTSFs
cultivated in serum-free medium for 5 days with and without
the addition of TGF-b1 (10 ng/ml). After the fifth day, cells
were trypsinized and replated on 10 mg/ml of plasma
fibronectin (pFN) for 3 hours. After 3 hours, cells were stained
for focal adhesions and parallel samples of live cells
subjected to centrifugation. Centrifugation was performed to
measure relative ability of cells to adhere to pFN. Focal
adhesion measurements (15 cells, B1,500 focal adhesions,
three separate experiments) indicated that HFFs with TGF-b1
as well as, HTSFs with or without TGF-b1, contained five
times more supermature focal adhesions (Figure 6b–d)
(X6 mm2) compared to HFFs without TGF-b1 (Figure 6a),
which produced only smaller adhesions. Importantly, we
find that in both cell types the overall numbers of focal
adhesions per cell are comparable, whether treated or not, in
either cell type. When these cells were tested for adhesion
function, we observed a 2-fold increase in adhesion to pFN
(Figure 6b–d) by cells with supermature focal adhesions
compared to HFFs without TGF-b1 with smaller adhesions
(Figure 6e). In all, 38% of HFFs–TGF-b1 bound to pFN
compared to 92% of HFFsþ TGF-b1, and 90% of HTSFs with
and without TGF-b1. Focal adhesions in HTSFs matured and
caused tighter binding to pFN independent of exogenous
TGF-b1, consistent again with a mechanism involving
autocrine stimulation by TGF-b1. Importantly, the surface
area of all cells tested did not change significantly
(1170.8 mm2), nor did the number (B100) of vinculin-
positive adhesions per cell. Interestingly, these data also
suggest that focal adhesions reassemble promptly (after
trypsinization and replated in the absence of serum on
pFN) to the phenotype that was generated when cells were
cultivated in serum free conditions with or without the
addition of TGF-b1. Moreover, these results show a tight
correlation between focal adhesion size and adhesive activity
indicating that large adhesions aid in matrix binding.
We also tested the hypothesis that HTSFs contracted
collagen gels more avidly than did normal fibroblasts in the
absence of added stimulants of contraction, such as TGF-b1.
Collagen gels (1.5 mg/ml) were prepared, with embedded
cells, as hemispheres in tissue culture wells and the percent
of the initial height of the gel was measured as described
previously (Tilles et al., 2000). We observed that HTSFs
contracted collagen gels more avidly (to 37% of initial
height by 360 minutes) compared to normal fibroblasts
(HFFs) without (79% by 360 minutes) added TGF-b1
(Figure 7). To confirm that the HFFs were responsive, we
observed more robust prompt contraction when exogenous
TGF-b1 was added (50% initial height by 360 minutes).
Taken together, our data indicate that increased focal
adhesion area promotes increased matrix adhesion and
collagen contraction consistent with a role in the onset and/
or maintenance of fibro-contractive disorders such as
hypertrophic scars.
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Figure 6. Cells that contained a larger number of supermature focal
adhesions adhere tighter to pFN. HTSFs and HFFs were incubated in serum-
free media with or without TGF-b1 (10 ng/ml) for 5 days then trypsinized and
replated onto pFN (10 mg/ml) for 3 hours. After 3 hours, cells were stained and
focal adhesions were measured as described in Figures 1 and 2. Cells from the
same experiment were also centrifuged at 650 g for 10 minutes and the
percent of cell binding was calculated as a ratio: (#of cells after spin)/(# cells
initially present) multiplied by 100 (e). Cells that contained larger focal
adhesions bound tighter to pFN (b–d) compared to HFFs without TGF-b1 (a).
*Po0.05 compared to HFF without TGF-B. ( X0.1 mm2, o6 mm2),
( X6 mm2, o10 mm2), ( X10 mm2, o15 mm2), ( X15 mm2, o20 mm2),
( X20mm2, o25mm2), ( X25mm2, o30mm2), ( X30mm2, o50mm2).
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Figure 7. HTSFs contract collagen gels more rapidly than do normal
fibroblasts in the absence of exogenous TGF-b1. HTSFs (circle) or HFFs
(squares) were cultured on collagen gels (1.5 mg/ml; 0.1 ml; 50,000 cells) for
the indicated times and the decrease in height (z dimension) measured by
phase microscopy using a purpose-built micrometer (Tilles et al., 2000). HFFs
were incubated in the absence (open squares) or presence (filled squares) of
exogenous TGF-b1 (10 ng/ml) as a control. The data are presented as the
percent of initial height.
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DISCUSSION
The deposited ECM occurring as a result of normal scar
formation results from a finely regulated balance of the
synthesis, deposition, and degradation of its protein compo-
nents. Although TGF-b1 is a well-established key regulator of
all these processes during ECM remodeling, its role in
pathogenic scarring is less well understood. A prominent
model holds that the balance which normally occurs in ECM
synthesis, deposition, and degradation during the remodeling
phase of wound healing is disrupted by deregulated TGF-b1
signaling in pathogenic scarring (Tuan and Nichter, 1998;
Eickelberg, 2001; Reisdorf et al., 2001). In normal wound
healing, active TGF-b1 has also been shown to promote
the formation of the structural elements important in
the myofibroblast phenotype, including SMCA synthesis,
focal adhesion complex formation, and FN fibril assembly
(Grinnell, 1994; Desmouliere, 1995; Vaughan et al., 2000;
Dugina et al., 2001; Gabbiani, 2003; Hinz et al., 2003). We
now report that fibroblasts derived from hypertrophic scars
stably elaborate an autocrine system for induction of TGF-b1
that promotes the assembly and maintenance of large focal
adhesions. This autocrine induction was inhibited with a
soluble TGF-b receptor mimetic that binds to and inhibits
active TGF-b1 suggesting that these cells generate active,
from latent, TGF-b1. The presence of very large focal
adhesions in HTSFs correlated with increased adhesion to
pFN and increased collagen gel contraction. Our data
support a model in which induction of large focal adhesions
promotes myofibroblast adhesion to ECM and wound
contraction.
TGF-b1 is a major cytokine secreted from degranulated
platelets during the initial stages of wound healing and by
macrophages within days following injury. Hypertrophic scar
fibroblasts produce more TGF-b1 mRNA and protein than
normal fibroblasts (Ghahary et al., 1993, 1996; Wang et al.,
2000). Indeed, we observe by ELISA that HTSFs secrete
higher levels of active and latent TGF-b1 compared to normal
fibroblasts. Whether HTSFs are also able to activate latent
TGF-b1 or orient active TGF-b1 more favorably to the type II
receptor than do normal fibroblasts is not known. Betaglycan
(TGF-b type III receptor) function, reported to promote
ligation of TGF-b1 to the TGF-b type II and I receptors, may
also enhance TGF-b function in HTSFs (Lopez-Casillas et al.,
1993). The levels and activities of betaglycan on HTSFs are
currently unknown. However, our data also indicate that the
overexpression of TGF-b1 in culture is stable in HTSFs.
We report here experiments extending the deregulated
TGF-b1 signaling hypothesis using focal adhesion maturation
as a marker. We observe that pathogenic fibroblasts isolated
from hypertrophic scars are activated by TGF-b1 via an
autocrine loop and that HTSFs constitutively express large
focal adhesions. These larger adhesions can be inhibited by
the addition of the soluble receptor chimera, Tb1RA. The
dependence of TGF-b1 in focal adhesion maturation was
shown when HFF cells transduced with active TGF-b1
expressed larger focal adhesions compared to its latent
control. Balaban et al. (2001) determined that focal adhesion
force transmission is linearly proportional to their size.
Moreover, increases in contractility increase focal adhesion
size (Chrzanowska-Wodnicka and Burridge, 1996). Hinz
et al. (2001, 2003) have shown that increased SMCA
expression correlates with enhanced fibroblast contractile
activity, focal adhesion assembly and adhesion.
We observed that larger adhesions correlated with
stronger adhesive strength to pFN, using our modified cell
adhesion assay. Replating cells on pFN provides the means to
test the extent to which pathogenic myofibroblasts during
wound healing are able to bind tighter to matrix via focal
adhesions. We speculate that this tighter binding together
with increased contractility contribute to the excessive
contraction seen in HTSFs (Nedelec et al., 2000; Shin and
Minn, 2004). Indeed, HTSFs contracted collagen gels more
vigorously without added TGF-b than did normal HFFs.
Importantly, larger focal adhesions, and thus tighter binding
to matrix in HTSFs, occurred independently of exogenous
TGF-b1 but depended on autocrine production and activa-
tion. Interestingly, after trypsinization, focal adhesions were
able to reassemble promptly (within three hours) to the same
phenotype that was generated before trypsinization (Figures 1
and 2) when cells were replated on pFN in serum-free
conditions (Figure 6). After 3 hours, the cells spread to the
same area and contained the same number of vinculin-
positive structures (see Figures 1 and 2). Throughout our
experiments, serum-free conditions were maintained and the
only cytokine present in the medium was TGF-b1. Therefore,
we demonstrate here a strong correlation between autocrine
induction of TGF-b1, focal adhesion maturation and thus,
tighter binding to matrix in pathogenic myofibroblast cells.
Determining how abundant TGF-b1 is activated in an
autocrine loop by HTSFs will provide a new basis for
understanding the pathogenesis of this disorder. Steps have
been taken clinically to disrupt the factors that regulate this
scarring phenomenon such as inter-lesional injection of an
antagonist to TGF-b1, steroid injections, and the use of
antifibrotic agents such as IL-1 and tumor necrosis factor-a
(Tuan and Nichter, 1998). However, more effective therapies
will come from a detailed understanding of the defect in the
regulatory network in these fibroblasts that leads to the
autocrine stimulation of TGF-b1 which, as shown in our
work, generates very large focal adhesions, tighter binding to
matrix and enhanced collagen contraction.
MATERIALS AND METHODS
Materials
Normal adult dermal fibroblasts were purchased from Clonetics-
Cambrex BioScience (Walkersville, MD). TGF-b1 (R&D Systems,
Inc., Minneapolis, MN) was used at a concentration of 10 ng/ml for
all experiments. A recombinant TGF-b receptor chimera (Tb1RA)
that binds active TGF-b1 was a gift of Dr. Phillip Gotwals (Biogen-
Idec Corp., Boston, MA). This TGF-b1 antagonist (Tb1RA) was
prepared by fusing a truncated form (missing the transmembrane
region) of the TGF-b receptor type II to the Fc region of IgG,
rendering the receptor chimera soluble (Smith et al., 1999), and was
used at the designated concentrations. Collagenase (C-0130) and
anti-vinculin mAb (clone hVIN-1) were obtained from Sigma
Chemical Co., (St Louis, MO). Alexa Fluor 488 goat anti-mouse,
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Alexa Fluor 594 phalloidin were obtained from Molecular Probes
(Eugene, OR).
Cell culture
All fibroblasts used in these studies were cultured in complete
medium containing Dulbecco’s modification of Eagle’s minimum
essential medium (Gibco Invitrogen Corporation, Carlsbad, CA),
10% fetal bovine serum (Gibco Invitrogen Corporation, Carlsbad,
CA), and 1% penicillin–streptomycin (Gibco Invitrogen Corporation,
Carlsbad, CA) at 371C in a humid incubator with 5% CO2.
Human dermal fibroblasts (HFFs) were derived from neonatal
foreskins, obtained at the Women & Infants Hospital of Rhode
Island, Providence, RI. The HFFs were genetically modified as
previously described using a retrovirus encoding either wild-type
(latent) TGF-b1, that is secreted as a latent molecule and requires
activation, or a mutant form of TGF-b1 (cysteines 223 and 225 were
converted to serines), that is secreted as an active molecule and does
not require activation (Brunner et al., 1989; Le Doux et al., 2001).
HTSFs were isolated from biopsies taken from hypertrophic scars
resected therapeutically from pediatric patients at Shriners Burns
Hospital and Massachusetts General Hospital (Boston, MA). Tissue
was processed according to the protocol of Rønnov-Jessen and
Peterson (1993). In brief, tissue were minced, treated overnight
(371C) with collagenase solution (48 hours, 371C in 900 IU
collagenase per ml in serum-free Dulbecco’s minimum essential
medium). The liberated cells were fractionated by differential
centrifugation and cultured in Dulbecco’s minimum essential
medium. All tissues were acquired anonymously under protocols
approved by the relevant medical and ethical committees of the
Women & Infants Hospital of Rhode Island and the Massachusetts
General Hospital in accord with the Declaration of Helsinki
Principles.
To characterize the development of focal adhesions, cells were
cultured at 30% confluency in complete medium for 18 hours, then
washed with Dulbecco’s phosphate-buffered saline and serum-free
medium (Dulbecco’s minimum essential medium 1:1, Hams F12
1:1, transferrin 5mg/ml, insulin 5 107 M, ascorbate 0.2 mM,
glutamine 1 , penicillin–streptomycin 1 ) was added, followed
by 10 ng/ml of TGF-b1, where specified. Cells were allowed to
incubate at 371C in a humid incubator with 5% CO2 for 3, 4, or 5
days where specified.
Immunofluorescence and microscopy
Cells cultured in serum-free media (for either 3, 4, or 5 days), with or
without exogenous active TGF-b1 or Tb1RA, were washed with
Dulbecco’s phosphate-buffered saline (Gibco Invitrogen Interna-
tional, Carlsbad, CA), fixed with 3.7% formaldehyde in Dulbecco’s
phosphate-buffered saline, permeabilized with 0.5% Triton X-100
(Sigma Chemical Co., St Louis, MO), blocked with 2% BSA (Sigma
Chemical Co. St Louis, MO) in phosphate-buffered saline for 1 hour.
All primary and secondary antibodies were diluted in 2% BSA/
phosphate-buffered saline. Samples were then incubated sequen-
tially with either mAb against vinculin (1:400) (Sigma Chemical Co.,
St Louis, MO), or mouse IgG (1:100) (Sigma Chemical Co., St Louis,
MO) and then with a mixture of goat anti-mouse Alexa Fluor 488
(1:1,000) TRITC-conjugated phalloidin (1:100), and Hoechst 33342
(1:1,000) (Molecular Probes, Eugene, OR). Coverslips were mounted
in Gelmount (Biomedia Corp., Foster City, CA). Labeled cells were
observed with an Olympus BX60 microscope equipped with an
immersion oil objective ( 60/1.25, phase 3). Images were captured
with attached Cooke Sensicam digital camera and deconvolved
using Slidebook 3.0.10.3 software (FFTW licensed from Massachu-
setts Institute of Technology, Cambridge, MA).
Focal adhesion measurements
Cells (n¼ 20) were chosen that were not in contact with any other
cell and were well-spread but fit within the field of the magnification
so that the whole cell could be seen in a single frame. A single
immunofluorescence image of vinculin within the cell was obtained
along with a triple labeled image (anti-vinculin, phalloidin, and
Hoechst). The latter image provided information important for
defining focal adhesions (both phalloidin and vinculin positive) and
the two images were kept parallel to one another. Vinculin staining
on the single label immunofluorescence was then measured for area
(mm2) of focal adhesion using Image Pro-Plus version 4.5.1.26
(Media Cybermatic, Silver Spring, MD). The limits set for measure-
ment was 0.1–50 mm2 (6.34 pixels/mm).
Conditioned medium
Initially cells were plated in 60 mm tissue culture plates as previously
described and allowed to incubate for 5 days in serum-free medium,
with or without active TGF-b1, to generate conditioned medium. On
the fourth day of incubation, in a separate LabTekTM chamber,
‘‘indicator’’ HFF cells were cultured in serum-containing medium for
18 hours, and washed with Dulbecco’s phosphate-buffered saline.
Conditioned medium from the 60 mm tissue culture plates was then
transferred to the indicator HFF cells for 5 days. In some instances,
Tb1RA (150–200mg/ml) was added immediately after the transfer of
conditioned medium to the indicator HFF cells. Indicator HFF cells
treated with conditioned medium was incubated for 5 days, the
medium was removed and the cells were immunostained for focal
adhesions as described above.
Adhesion and collagen contraction assays
Cells cultivated in serum-free medium for 5 days, with or without
10 ng/ml of TGF-b1, were trypsinized and replated onto 10 mg/ml of
pFN and allowed to incubate for 3 hours at 371C in 5% CO2 before
measurement of focal adhesion area (as above) and adhesive
activity. To identify the location of cells, a Microslide Field Grid
Finder (Fisher Scientific, Atlanta, GA) was attached to the bottom of
the two-well LabTekTM chamber (Nalge Nunc International, Naper-
ville, IL), which contained the cultured cells. Under phase contrast
microscopy, an area in the middle of the chamber was selected
where the cells were evenly spread and not in contact and an image
was taken showing the number of cells initially present. The
chamber was then submerged in a container filled with phosphate-
buffered saline and inverted so that no air bubbles would form. Cells
were centrifuged (650 g, Eppendorf Centrifuge 5810R, Hamburg,
Germany) for 10 minutes, and the original grid address was located
microscopically and another image was taken. The percentage of
cells that remained adherent was calculated as follows: number of
cells that remained after spin divided by the number of cells initially
present, multiplied by 100.
Cells were tested in collagen contraction assays using our
modification of the stressed gel model (Grinnell, 1994; Tilles et al.,
2000). In brief, HTSFs or HFFs were cultured on collagen gels
www.jidonline.org 969
G Dabiri et al.
Focal Adhesion Maturation in Pathogenic Fibroblasts
(1.5 mg/ml; 0.1 ml; 50,000 cells) for an interval of 0–6 hours and the
decrease in height (z dimension) measured by phase microscopy
using a purpose-built micrometer (Tilles et al., 2000). In some wells,
recombinant, active TGF-b (10 ng/ml) was added. The percent of the
initial height was determined.
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